The line between “white collar crime” and “street crime” is often blurred as prosecutors and investigators deploy all of the tools at their disposal against white collar and regulatory offenses. Principal among these tools is the search warrant.
White House Office of Management and Budget Proposes Revising Circular a-119 Regarding Government Standards Acitivites
A few weeks ago, the White House Office of Management and Budget’s (OMB) proposed revisions to Circular A-119 entitled “Federal Participation in the Development and Use of Voluntary Consensus Standards and in Conformity Assessment Activities.” In this post we provide an overview of OMB’s proposed 60+-page revised Circular A-119.
Who is Protected by the Sarbanes-Oxley and Dodd-Frank Whistleblower Anti-Retaliation Provisions? the Supreme Court and SEC Weigh in.
The Sarbanes-Oxley Act (“Sarbanes-Oxley”) and Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank”) whistleblower anti-retaliation provisions have been the subject of great debate as to what categories of individuals and activities are protected.
DC Week Ahead: The U.S. House Appropriations Committee hears four days of testimony on President Barack Obama’s fiscal 2015 budget plan, SCOTUS releases opinions, House is in, Senate is in and the Senate Banking Committee weighs the nominations of Stanley Fischer, Jerome Powell, and Lael Brainard for the Federal Reserve Board.
Morning Regulatory Review: Obamacare Delays & Exceptions; Regulatory Budget; EPA Tier 3 Vehicle Emissions
Last week heard significant noise in the regulatory world with very little actual substantive movement.
Implementing a promise from his State of the Union Address, President Obama issued Executive Order (“E.O.”) 13658 on February 12, 2014, imposing a mandatory minimum wage of $10.10 per hour for some Federal prime contracts and subcontracts.
For several years now current good manufacturing practice (cGMP) violations have been viewed as “the next hot thing” in False Claims Act (FCA) litigation.
FDA Finalizes Guidance On Drug Chemistry, Manufacturing, and Controls Postapproval Changes, Allows More to Be Submitted in Annual Reports
Over the years, the number of chemistry, manufacturing, and controls (CMC) postapproval drug manufacturing supplements for NDAs and ANDAs submitted to FDA has continued to increase.
District of Columbia Dismisses Lawsuit Seeking to Place Attorney General on April Ballots
DC Week Ahead: POTUS releases FY2015 budget proposal, House is in, Senate is in, SecState Kerry meets with Ukrainian leaders in Kiev, Unemployment report on Friday.